WORLD S. Africa welcomes WHO's approval of China's Sinovac COVID-19 vaccine


S. Africa welcomes WHO's approval of China's Sinovac COVID-19 vaccine


08:36, June 05, 2021

CAPE TOWN, June 4 (Xinhua) -- South African President Cyril Ramaphosa has welcomed the World Health Organization (WHO)'s approval of the COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech for emergency use.

A staff member of Sinovac Biotech, a Chinese biopharmaceutical company, displays a dose of COVID-19 inactivated vaccine in Schering bottle package in Beijing, capital of China, Dec. 23, 2020. (Photo: Xinhua)

"As we accelerate the rollout of vaccines, we continue to engage various manufacturers to ensure a reliable and diverse supply of vaccines. We therefore welcome the news that the World Health Organization has validated the Sinovac COVID-19 vaccine for emergency use," Ramaphosa told the National Assembly on Wednesday.

He called the approval "a crucial step," saying it will pave the way for South African health product regulators to consider purchasing the Sinovac vaccine, according to a release from the presidency.

He hopes the approval will mean more vaccines for his population and those in poorer countries.

"No country in the world has been spared the impacts of the coronavirus, demonstrating how inter-connected and inter-dependent we are," he said, adding that no country can hope to overcome the pandemic alone.

On Tuesday, the Sinovac vaccine became the second one from China included in the WHO Emergency Use Listing, following the Sinopharm vaccine, which was validated last month.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue